News

The $69 billion merger between Aetna, one of the nation’s largest health insurers, and CVS, a major retail pharmacy chain and pharmacy benefit manager, has been touted as a “transformative moment” moment for the healthcare industry. Now that the deal has been completed, consumers are split on whether they'll move their care to the retailer. 

In the latest twist in the debate over the long-term safety of paclitaxel-coated balloons and stents, a correction published Feb. 19 in Circulation said the five-year mortality results of the Zilver PTX randomized trial were “inadvertently reversed”—and that uncoated devices were actually associated with better survival. 

Most women are willing to wait for their screening mammogram results after the exam or receive their test results within 48 hours, according to new research published in the Journal of the American College of Radiology

Stereotactic ablative body radiation therapy (SABR) nearly doubled the overall survival of patients with inoperable stage I lung cancer compared to standard radiotherapy, according to results of a multi-center phase III trial published in Lancet Oncology.

The American Heart Association announced on Feb. 20 it launched a series of quick online reference tools for physicians and their patients who struggle with high blood pressure, including a list of four of the most common mistakes hypertensives can make on a daily basis.

Joseph J. Cappello, executive director of Are You Dense and Are You Dense Advocacy, spoke to Radiology Business about how it felt to finally see federal breast density notification requirements signed into law.

After acquiring Aetna for nearly $70 billion, CVS Health has taken a financial hit. During the three months ending Dec. 31, 2018, CVS Health lost $421 million in net income, according to its end-of-year financial results.

The FDA has approved nerve stimulation for treatment of episodic and chronic cluster headaches and acute migraines. The findings, detailed in a study published online Feb. 13 in PLOS ONE, could help personalize treatment for PTSD, which according to the National Institute of Mental Health impacts roughly 3.6 percent of U.S. adults per year. 

Apple could look to prioritize its AI efforts as iPhone sales decrease and the company seeks other growth areas, according to a recent report by CNBC.

A study published Feb. 14 in the American Journal of Cardiology suggests obese patients with atrial fibrillation (AF) fare better in terms of mortality and stroke events than their non-obese counterparts—a finding that’s in line with the much-contested “obesity paradox."

Paige.AI, a start-up that uses AI to diagnose and treat cancer, announced the appointment of Leo Grady, PhD, as its new CEO and a member of its board of directors. Paige.AI was recently named a top startup in CB Insight's third annual AI 100 list.

Autosomal dominant polycystic kidney disease (ADPKD) is among the most common hereditary diseases and is associated with complications such as intracranial aneurysm. A lack of screening guidelines prompted a group of researchers to evaluate the cost-effectiveness of various MR angiography strategies.